Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors.
Tong, Y., Claiborne, A., Stewart, K.D., Park, C., Kovar, P., Chen, Z., Credo, R.B., Gu, W.Z., Gwaltney, S.L., Judge, R.A., Zhang, H., Rosenberg, S.H., Sham, H.L., Sowin, T.J., Lin, N.H.(2007) Bioorg Med Chem 15: 2759-2767
- PubMed: 17287122 
- DOI: 10.1016/j.bmc.2007.01.012
- Primary Citation of Related Structures:  
2E9O, 2E9N - PubMed Abstract: 
A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening. The efficient hit-to-lead process was facilitated by X-ray crystallography and led to p ...